title: Dairy products and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition.
abstract: Intake of dairy products has been associated with risk of some cancers, but findings are often inconsistent and information on hepatocellular carcinoma (HCC) risk is limited, particularly from prospective settings. The aim of our study was to investigate the association between consumption of total and specific dairy products (milk/cheese/yogurt) and their components (calcium/vitamin D/fats/protein), with first incident HCC (N(cases) = 191) in the European Prospective Investigation into Cancer and Nutrition cohort, including a nested case-control subset (N(cases) = 122) with the assessment of hepatitis B virus/hepatitis C virus infections status, liver damage and circulating insulin-like growth factor (IGF)-I levels. For cohort analyses, multivariable-adjusted Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (95% CI). For nested case-control analyses, conditional logistic regression was used to calculate odds ratios and 95% CI. A total of 477,206 participants were followed-up for an average of 11 years (person-years follow-up = 5,415,385). In the cohort study, a significant positive HCC risk association was observed for total dairy products (highest vs. lowest tertile, HR = 1.66, 95% CI: 1.13-2.43; p(trend) = 0.012), milk (HR = 1.51, 95% CI: 1.02-2.24; p(trend) = 0.049), and cheese (HR = 1.56, 95% CI: 1.02-2.38; p(trend) = 0.101), but not yogurt (HR = 0.94, 95% CI: 0.65-1.35). Dietary calcium, vitamin D, fat and protein from dairy sources were associated with increased HCC risk, whereas the same nutrients from nondairy sources showed inverse or null associations. In the nested case-control study, similar results were observed among hepatitis-free individuals. Results from this large prospective cohort study suggest that higher consumption of dairy products, particularly milk and cheese, may be associated with increased HCC risk. Validation of these findings in other populations is necessary. Potential biologic mechanisms require further exploration.
authors.affiliation: International Agency for Research on Cancer (IARC-WHO), Lyon, France.
authors.forename: Talita
authors.initials: T
authors.lastname: Duarte-Salles
authors.forename: Veronika
authors.initials: V
authors.lastname: Fedirko
authors.forename: Magdalena
authors.initials: M
authors.lastname: Stepien
authors.forename: Antonia
authors.initials: A
authors.lastname: Trichopoulou
authors.forename: Christina
authors.initials: C
authors.lastname: Bamia
authors.forename: Pagona
authors.initials: P
authors.lastname: Lagiou
authors.forename: Annekatrin
authors.initials: A
authors.lastname: Lukanova
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Trepo
authors.forename: Kim
authors.initials: K
authors.lastname: Overvad
authors.forename: Anne
authors.initials: A
authors.lastname: Tjønneland
authors.forename: Jytte
authors.initials: J
authors.lastname: Halkjaer
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Boutron-Ruault
authors.forename: Antoine
authors.initials: A
authors.lastname: Racine
authors.forename: Claire
authors.initials: C
authors.lastname: Cadeau
authors.forename: Tilman
authors.initials: T
authors.lastname: Kühn
authors.forename: Krasimira
authors.initials: K
authors.lastname: Aleksandrova
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Trichopoulos
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Tsiotas
authors.forename: Paolo
authors.initials: P
authors.lastname: Boffetta
authors.forename: Domenico
authors.initials: D
authors.lastname: Palli
authors.forename: Valeria
authors.initials: V
authors.lastname: Pala
authors.forename: Rosario
authors.initials: R
authors.lastname: Tumino
authors.forename: Carlotta
authors.initials: C
authors.lastname: Sacerdote
authors.forename: Salvatore
authors.initials: S
authors.lastname: Panico
authors.forename: H B as
authors.initials: HB
authors.lastname: Bueno-de-Mesquita
authors.forename: Vincent K
authors.initials: VK
authors.lastname: Dik
authors.forename: Petra H
authors.initials: PH
authors.lastname: Peeters
authors.forename: Elisabete
authors.initials: E
authors.lastname: Weiderpass
authors.forename: Inger
authors.initials: I
authors.lastname: Torhild Gram
authors.forename: Anette
authors.initials: A
authors.lastname: Hjartåker
authors.forename: Jose
authors.initials: J
authors.lastname: Ramón Quirós
authors.forename: Ana
authors.initials: A
authors.lastname: Fonseca-Nunes
authors.forename: Esther
authors.initials: E
authors.lastname: Molina-Montes
authors.forename: Miren
authors.initials: M
authors.lastname: Dorronsoro
authors.forename: Carmen
authors.initials: C
authors.lastname: Navarro Sanchez
authors.forename: Aurelio
authors.initials: A
authors.lastname: Barricarte
authors.forename: Björn
authors.initials: B
authors.lastname: Lindkvist
authors.forename: Emily
authors.initials: E
authors.lastname: Sonestedt
authors.forename: Ingegerd
authors.initials: I
authors.lastname: Johansson
authors.forename: Maria
authors.initials: M
authors.lastname: Wennberg
authors.forename: Kay-Tee
authors.initials: KT
authors.lastname: Khaw
authors.forename: Nick
authors.initials: N
authors.lastname: Wareham
authors.forename: Ruth C
authors.initials: RC
authors.lastname: Travis
authors.forename: Isabelle
authors.initials: I
authors.lastname: Romieu
authors.forename: Elio
authors.initials: E
authors.lastname: Riboli
authors.forename: Mazda
authors.initials: M
authors.lastname: Jenab
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006528:Carcinoma, Hepatocellular / Q000209:etiology*; D016022:Case-Control Studies; D003611:Dairy Products / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009752:Nutritional Status; D011379:Prognosis; D011446:Prospective Studies; D012307:Risk Factors; D055815:Young Adult
keywords: calcium; dairy products; hepatocellular carcinoma; prospective cohort